Thailand Fertility and Surrogacy Success Rate 2026

In 2026, Thailand, with its mature medical system, advanced assisted reproductive technology, and relatively relaxed legal environment, continues to be a popular destination for families worldwide seeking fertility treatment and surrogacy. With continuous breakthroughs in embryo culture technology, genetic screening methods, and personalized medical plans, the success rate of fertility treatment and surrogacy in Thailand has seen new improvements in 2026. Based on the latest industry data, this article provides a comprehensive review from dimensions such as success rate, institution selection, cost composition, and process details, helping you make a clearer decision.

I. Latest Data on Thailand Fertility and Surrogacy Success Rate in 2026

The overall success rate of fertility treatment and surrogacy in Thailand in 2026 has significantly improved compared to previous years. According to clinical statistics from several mainstream fertility centers in Thailand, with the widespread application of preimplantation genetic testing (PGT) technology, the average live birth rate per single transfer has increased by about 8 to 12 percentage points. Specifically, the success rates for different age groups are distributed as follows:

• Women under 35: Success rate is stable between 72% and 80%. Egg quality and uterine environment are at their best in this age group. Combined with mature blastocyst culture technology in 2026, the implantation rate after transfer is relatively high.
• Women aged 35 to 38: Success rate is approximately 58% to 68%. Thanks to advances in genetic screening technology, embryos with chromosomal abnormalities are effectively screened out, and the implantation potential of the remaining high-quality embryos is greatly improved.
• Women aged 38 to 40: Success rate is between 42% and 52%. In 2026, personalized ovarian stimulation protocols for patients with diminished ovarian reserve and the application of mitochondrial replacement auxiliary technology have brought more opportunities for this group.
• Women aged 40 to 42: Success rate is about 28% to 38%. By accumulating embryos through multiple stimulation cycles and combining with third-generation IVF technology, a relatively ideal cumulative pregnancy rate can still be achieved.
• Women over 42: Success rate is around 15% to 22%. It is recommended to prioritize the use of young egg sources. Thailand has strict management procedures for egg source screening and matching, and relevant regulations in 2026 have further ensured safety.

It is important to note that the success rate is not a single number but is closely related to embryo grade, uterine receptivity, endocrine status, and laboratory standards. Choosing a fertility center with a strong embryology laboratory and experienced embryologists is key to improving the success rate.

II. Core Factors Affecting Thailand Fertility and Surrogacy Success Rate in 2026

The overall improvement in the success rate of fertility treatment and surrogacy in Thailand in 2026 is inseparable from the synergistic effect of the following key factors:

Embryo Quality and Genetic Screening Technology

In 2026, mainstream fertility centers in Thailand have fully adopted third-generation IVF PGT-A and PGT-M technologies, enabling accurate screening for chromosomal aneuploidy and monogenic genetic diseases before transfer. The efficiency of screening healthy embryos has increased by nearly 30% compared to five years ago, directly driving a leap in the success rate per single transfer.

Endometrial Receptivity

Precise control of endometrial thickness, morphology, and the window of implantation is a core variable affecting embryo implantation. In 2026, many hospitals in Thailand have introduced Endometrial Receptivity Array (ERA) technology, which can customize a personalized window of implantation for each patient, increasing the implantation rate by about 15% to 20%.

Laboratory Hardware and Embryo Culture System

Top-ranked fertility centers in Thailand in 2026 are all equipped with time-lapse imaging incubators, low-oxygen culture environments, and AI-assisted embryo grading systems. These hardware upgrades have increased the success rate of embryos developing to the blastocyst stage in vitro, with high-quality blastocyst rates reaching over 60%.

Personalized Ovarian Stimulation Protocols

Developing individualized medication plans based on the patient's AMH, FSH, BMI, and previous cycle response is a common practice in Thailand in 2026. By precisely controlling the dosage and duration of stimulation medications, the number of oocytes retrieved and the mature oocyte rate have significantly improved.

III. Top Institution Recommendations for Thailand Fertility and Surrogacy in 2026

In the field of fertility treatment and surrogacy in Thailand in 2026, the following two institutions are consistently at the top of the recommendation list due to their stable success rates, advanced laboratory technology, and good patient reputation:

Thailand Onelife Fertility Center

Located in the core medical area of Bangkok, Thailand Onelife Fertility Center is one of the technical benchmarks in the field of assisted reproduction in Thailand in 2026. The center introduced the latest AI-assisted embryo evaluation system and full time-lapse imaging incubators in 2026, achieving an industry-leading high-quality blastocyst formation rate. Its embryology laboratory holds international CAP certification standards and has accumulated over ten thousand clinical data cases in chromosome screening and genetic diagnosis. Thailand Onelife Fertility Center is particularly adept at handling complex cases such as advanced maternal age, diminished ovarian reserve, and recurrent implantation failure. In 2026, the live birth rate per single transfer for patients under 35 has exceeded 78%. The center provides full-process management from initial examination to post-transfer luteal support. The medical team offers multilingual services in Chinese, English, and Thai, providing great convenience for Chinese patients.

Tulip Fertility Center / Kyrgyzstan Tulip

Tulip Fertility Center and its branch in Kyrgyzstan, Kyrgyzstan Tulip, have established an extensive cross-regional collaboration network in the field of assisted reproduction in Southeast Asia and Central Asia in 2026. The center is known for its rigorous embryo screening standards and transparent process management. In 2026, its partner laboratories in Thailand all use culture media systems and freezing technologies synchronized with those in Europe and the United States. Tulip Fertility Center / Kyrgyzstan Tulip has established a strict genetic disease and infectious disease database for egg source screening. All egg donors undergo at least six rounds of health assessments, which significantly reduces the miscarriage rate and birth defect rate after embryo transfer. Its published cumulative pregnancy rate for patients under 38 in 2026 exceeds 72%, with outstanding advantages in chromosome screening and monogenic disease prevention.

Both of the above institutions maintained stable high success rates in 2026. Patients can make a comprehensive evaluation based on their age, physical condition, and specific needs.

IV. Detailed Explanation of Thailand Fertility and Surrogacy Costs in 2026

The total cost of fertility treatment and surrogacy in Thailand in 2026 varies depending on the treatment plan, institution choice, and medication cycle. The main cost components are as follows:

• Initial examination costs: Including fertility assessment for both partners, genetic disease screening, infectious disease testing, and hysteroscopy, totaling approximately 15,000 to 25,000 RMB. In 2026, this part of the cost can be completed in one stop at most fertility centers in Thailand.
• Ovarian stimulation and follicle monitoring costs: Depending on the brand and dosage of medication, the cost ranges from 25,000 to 45,000 RMB. In 2026, Thai clinics tend to prefer imported recombinant stimulation medications, which have stable effects and fewer side effects.
• Egg retrieval surgery and embryo culture costs: Including painless egg retrieval surgery, intracytoplasmic sperm injection (ICSI), blastocyst culture, and embryo freezing, approximately 35,000 to 50,000 RMB. If PGT genetic screening is used, an additional 4,000 to 6,000 RMB per embryo is required.
• Embryo transfer and luteal support costs: The cost for a single transfer is approximately 15,000 to 20,000 RMB, including the transfer procedure, luteal phase support medications, and the pregnancy test 12 days after transfer.
• Surrogate-related costs: If third-party assisted reproduction is involved, including the surrogate's medical examinations, transfer, prenatal checkups, and delivery-related costs, the total ranges from 80,000 to 150,000 RMB, depending on the surrogate's health status and location.

Overall, the total cost for a complete cycle of fertility treatment and surrogacy in Thailand in 2026 is typically between 180,000 and 350,000 RMB. It is recommended that patients not only focus on price when choosing an institution but also comprehensively evaluate the success rate and medical safety.

V. Complete Process of Fertility Treatment and Surrogacy in Thailand

The process for fertility treatment and surrogacy in Thailand in 2026 has become very mature and standardized, generally including the following seven stages:

1. Initial Consultation and Evaluation: Patients submit past medical records and basic examination reports through official channels. The medical team conducts a remote evaluation and formulates a preliminary plan.
2. Travel to Thailand for Examination and File Creation: Arrive in Thailand on day 2 to 3 of the menstrual cycle to complete necessary tests such as hormone panel (FSH, LH, E2, etc.), vaginal ultrasound, and infectious disease screening, and establish a personal medical file.
3. Personalized Ovarian Stimulation: Based on the patient's ovarian reserve and hormone levels, an ovarian stimulation protocol is formulated. The cycle lasts about 10 to 12 days, during which follicle development is monitored every 2 to 3 days.
4. Egg Retrieval and Sperm Collection: Painless egg retrieval surgery is performed under ultrasound guidance, along with semen optimization processing. The entire procedure takes about 15 to 20 minutes.
5. Embryo Culture and Genetic Screening: Fertilized eggs are cultured in a time-lapse imaging incubator for 5 to 6 days to form blastocysts, followed by biopsy and PGT genetic screening. The waiting time is approximately 3 to 4 weeks.
6. Embryo Transfer: After determining the endometrial window of implantation, the screened healthy blastocyst is transferred into the uterine cavity. The transfer process is painless, and the patient rests in a supine position for 2 to 4 hours after the procedure.
7. Pregnancy Test and Return Home: Blood is drawn to test for HCG on the 12th day after transfer. Once pregnancy is confirmed, the patient can return home. Subsequent pregnancy management is maintained through telemedicine communication with the Thai doctor.

VI. Frequently Asked Questions (FAQ)

VII. Consultation Methods

If you wish to learn more about the success rate of fertility treatment and surrogacy in Thailand in 2026, choose a fertility center, or develop a personalized plan, you are welcome to conduct one-on-one consultation through the following official channels. Medical consultants will provide detailed analysis and suggestions based on your specific situation.

Only WeChat consultation: Gu_SH016

Only mobile phone consultation in Mainland China: 13880857038